The company is mainly engaged in the research and development of related compounds in the development of new drugs, research and development of characteristic pharmaceutical APIs, advanced intermediates, organic synthetic blocks, high-end reagents, etc. At the same time, the company also provides entrusted development and production technology improvement services for domestic and foreign pharmaceutical enterprises, universities and scientific research institutions.

Special services include: mainly engaged in preclinical compound standards, and related research of supporting impurities.